Global Ophthalmology Disorders Drug Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Ophthalmology Disorders Drug Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Oral
  • 1.4.3 Injection
  • 1.4.4 External Use
• 1.5 Market by Application
  • 1.5.1 Global Ophthalmology Disorders Drug Market Share by Application (2019-2025)
  • 1.5.2 Juvenile Macular Degeneration (Stargardt Disease)
  • 1.5.3 Leber Congenital Amaurosis (LCA)
  • 1.5.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
  • 1.5.5 Usher Syndrome
  • 1.5.6 Retinitis Pigmentosa (Retinitis)
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Ophthalmology Disorders Drug Market Size
• 2.2 Ophthalmology Disorders Drug Growth Trends by Regions
  • 2.2.1 Ophthalmology Disorders Drug Market Size by Regions (2019-2025)
  • 2.2.2 Ophthalmology Disorders Drug Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Ophthalmology Disorders Drug Market Size by by Players
  • 3.1.1 Global Ophthalmology Disorders Drug Revenue by by Players (2014-2019)
  • 3.1.2 Global Ophthalmology Disorders Drug Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Ophthalmology Disorders Drug Market Concentration Ratio (CR5 and HHI)
• 3.2 Ophthalmology Disorders Drug Key Players Head office and Area Served
• 3.3 Key Players Ophthalmology Disorders Drug Product/Solution/Service
• 3.4 Date of Enter into Ophthalmology Disorders Drug Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Ophthalmology Disorders Drug Market Size by Type (2014-2019)
• 4.2 Global Ophthalmology Disorders Drug Market Size by Application (2014-2019)

5 North America

• 5.1 North America Ophthalmology Disorders Drug Market Size (2014-2019)
• 5.2 Ophthalmology Disorders Drug Key Players in North America
• 5.3 North America Ophthalmology Disorders Drug Market Size by Type
• 5.4 North America Ophthalmology Disorders Drug Market Size by Application

6 Europe

• 6.1 Europe Ophthalmology Disorders Drug Market Size (2014-2019)
• 6.2 Ophthalmology Disorders Drug Key Players in Europe
• 6.3 Europe Ophthalmology Disorders Drug Market Size by Type
• 6.4 Europe Ophthalmology Disorders Drug Market Size by Application

7 China

• 7.1 China Ophthalmology Disorders Drug Market Size (2014-2019)
• 7.2 Ophthalmology Disorders Drug Key Players in China
• 7.3 China Ophthalmology Disorders Drug Market Size by Type
• 7.4 China Ophthalmology Disorders Drug Market Size by Application

8 Japan

• 8.1 Japan Ophthalmology Disorders Drug Market Size (2014-2019)
• 8.2 Ophthalmology Disorders Drug Key Players in Japan
• 8.3 Japan Ophthalmology Disorders Drug Market Size by Type
• 8.4 Japan Ophthalmology Disorders Drug Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Ophthalmology Disorders Drug Market Size (2014-2019)
• 9.2 Ophthalmology Disorders Drug Key Players in Southeast Asia
• 9.3 Southeast Asia Ophthalmology Disorders Drug Market Size by Type
• 9.4 Southeast Asia Ophthalmology Disorders Drug Market Size by Application

10 India

• 10.1 India Ophthalmology Disorders Drug Market Size (2014-2019)
• 10.2 Ophthalmology Disorders Drug Key Players in India
• 10.3 India Ophthalmology Disorders Drug Market Size by Type
• 10.4 India Ophthalmology Disorders Drug Market Size by Application

11 Central & South America

• 11.1 Central & South America Ophthalmology Disorders Drug Market Size (2014-2019)
• 11.2 Ophthalmology Disorders Drug Key Players in Central & South America
• 11.3 Central & South America Ophthalmology Disorders Drug Market Size by Type
• 11.4 Central & South America Ophthalmology Disorders Drug Market Size by Application

12 International Players Profiles

• 12.1 Sanofi
  • 12.1.1 Sanofi Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Ophthalmology Disorders Drug Introduction
  • 12.1.4 Sanofi Revenue in Ophthalmology Disorders Drug Business (2014-2019))
  • 12.1.5 Sanofi Recent Development
• 12.2 Bayer
  • 12.2.1 Bayer Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Ophthalmology Disorders Drug Introduction
  • 12.2.4 Bayer Revenue in Ophthalmology Disorders Drug Business (2014-2019)
  • 12.2.5 Bayer Recent Development
• 12.3 Bausch + Lomb
  • 12.3.1 Bausch + Lomb Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Ophthalmology Disorders Drug Introduction
  • 12.3.4 Bausch + Lomb Revenue in Ophthalmology Disorders Drug Business (2014-2019)
  • 12.3.5 Bausch + Lomb Recent Development
• 12.4 Novartis
  • 12.4.1 Novartis Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Ophthalmology Disorders Drug Introduction
  • 12.4.4 Novartis Revenue in Ophthalmology Disorders Drug Business (2014-2019)
  • 12.4.5 Novartis Recent Development
• 12.5 Usher Syndrome
  • 12.5.1 Usher Syndrome Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Ophthalmology Disorders Drug Introduction
  • 12.5.4 Usher Syndrome Revenue in Ophthalmology Disorders Drug Business (2014-2019)
  • 12.5.5 Usher Syndrome Recent Development
• 12.6 Takeda Pharmaceutical
  • 12.6.1 Takeda Pharmaceutical Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Ophthalmology Disorders Drug Introduction
  • 12.6.4 Takeda Pharmaceutical Revenue in Ophthalmology Disorders Drug Business (2014-2019)
  • 12.6.5 Takeda Pharmaceutical Recent Development
• 12.7 Roche
  • 12.7.1 Roche Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Ophthalmology Disorders Drug Introduction
  • 12.7.4 Roche Revenue in Ophthalmology Disorders Drug Business (2014-2019)
  • 12.7.5 Roche Recent Development
• 12.8 Pfizer
  • 12.8.1 Pfizer Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Ophthalmology Disorders Drug Introduction
  • 12.8.4 Pfizer Revenue in Ophthalmology Disorders Drug Business (2014-2019)
  • 12.8.5 Pfizer Recent Development
• 12.9 Allergan
  • 12.9.1 Allergan Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Ophthalmology Disorders Drug Introduction
  • 12.9.4 Allergan Revenue in Ophthalmology Disorders Drug Business (2014-2019)
  • 12.9.5 Allergan Recent Development
• 12.10 Gilead Sciences
  • 12.10.1 Gilead Sciences Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Ophthalmology Disorders Drug Introduction
  • 12.10.4 Gilead Sciences Revenue in Ophthalmology Disorders Drug Business (2014-2019)
  • 12.10.5 Gilead Sciences Recent Development
• 12.11 Kubota Pharmaceutical
• 12.12 Alkeus Pharmaceuticals
• 12.13 Astellas Pharma
• 12.14 Ferrer Corporate
• 12.15 Amgen Inc
• 12.16 Editas Medicine Inc
• 12.17 ProQR Therapeutics NV
• 12.18 ReNeuron
• 12.19 Amarantus BioScience
• 12.20 Ocugen
• 12.21 ReGenX Biosciences
• 12.22 Sucampo Pharmaceuticals
• 12.23 Orphagen Pharmaceuticals
• 12.24 Okuvision
• 12.25 Second Sight Medical
• 12.26 Acucela
• 12.27 Stealth BioTherapeutics
• 12.28 Sun Pharma Advanced Research Company
• 12.28 AmpliPhi Biosciences
• 12.40 Applied Genetic Technologies
• 12.31 Asklepios BioPharmaceutical
• 12.32 Biovista
• 12.33 Spark Therapeutics
• 12.34 Caladrius Biosciences
• 12.35 Dompe Farmaceutici
• 12.36 Dormant Projects
• 12.37 Grupo Ferrer Internacional
• 12.38 ID Pharma
• 12.39 InFlectis BioScience
• 12.40 Ionis Pharmaceuticals
• 12.41 Ixchel Pharma
• 12.42 Khondrion
• 12.43 Mimetogen Pharmaceuticals
• 12.44 Mitotech
• 12.45 M's Science
• 12.46 Nanovector
• 12.47 SanBio

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Product (2019-2025)
• 13.2 Market Size Forecast by Application (2019-2025)
• 13.3 Market Size Forecast by Regions
• 13.4 North America
• 13.5 Europe
• 13.6 China
• 13.7 Japan
• 13.8 Southeast Asia
• 13.9 India
• 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer